Bangladeshi company Globe Biotech will seek government approval to start clinical trials of its Covid-19 vaccine this month, having already completed successful animal trials in the pre-clinical stage.
The company will seek approval through a contract research organisation (CRO) to start the first phase of human trials of the vaccine to examine whether the dose is safe and effective for humans.
The pharmaceutical company claimed they have gotten encouraging results from pre-clinical trials, initially done on rabbits and then mice.
The pre-clinical trial results were pre-published in the internationalplatform, biorxive.org -- an archive for unpublished pre-prints in life sciences. and the company is likely to hold a press conference in this regard early next week, Asif Mahmud, in-charge of research and development of Globe Biotech limited, told The Daily Star yesterday.
